Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease Evidence Review and Practical Considerations

被引:10
|
作者
Copeland, Carla R. [1 ]
Collins, Bridget F. [2 ]
Salisbury, Margaret L. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37235 USA
[2] Univ Washington, Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
environmental lung disease; hypersensitivity pneumonitis; pulmonary fibrosis; IDIOPATHIC PULMONARY-FIBROSIS; OCCUPATIONAL HYPERSENSITIVITY PNEUMONITIS; ASTHMA MORBIDITY; FARMERS LUNG; RISK-FACTORS; CIGARETTE-SMOKING; PROTECTIVE VALUE; MULTI-TRIGGER; ANTIGEN; METAL;
D O I
10.1016/j.chest.2021.02.021
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A relationship between inhalational exposure to materials in the environment and development of interstitial lung disease (ILD) is long recognized. Hypersensitivity pneumonitis is an environmentally -induced diffuse parenchymal lung disease. In addition to hypersensitivity pneumonitis, domestic and occupational exposures have been shown to influence onset and progression of other ILDs, including idiopathic interstitial pneumonias such as idiopathic pulmonary fibrosis. A key component of the clinical evaluation of patients presenting with ILD includes elucidation of a complete exposure history, which may influence diagnostic classification of the ILD as well as its management. Currently, there is no standardized approach to environmental evaluation or remediation of potentially harmful exposures in home or workplace environments for patients with ILD. This review discusses evidence for environmental contributions to ILD pathogenesis and draws on asthma and occupational medicine literature to frame the potential utility of a professional evaluation for environmental factors contributing to the development and progression of ILD. Although several reports suggest benefits of environmental assessment for those with asthma or certain occupational exposures, lack of information about benefits in broader populations may limit application. Determining the feasibility, long-term outcomes, and cost-effectiveness of environmental evaluation and remediation in acute and chronic ILDs should be a focus of future research.
引用
收藏
页码:219 / 230
页数:12
相关论文
共 50 条
  • [1] Environmental and occupational exposures in interstitial lung disease
    Lee, Cathryn T.
    Feary, Johanna
    Johannson, Kerri A.
    CURRENT OPINION IN PULMONARY MEDICINE, 2022, 28 (05) : 414 - 420
  • [2] Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review
    Laria, Antonella
    Lurati, Alfredo Maria
    Zizzo, Gaetano
    Zaccara, Eleonora
    Mazzocchi, Daniela
    Re, Katia Angela
    Marrazza, Mariagrazia
    Faggioli, Paola
    Mazzone, Antonino
    FRONTIERS IN MEDICINE, 2022, 9
  • [3] Development and evaluation of a questionnaire to capture environmental and occupational inhalational exposures in adults with fibrotic interstitial lung disease
    Swaminathan, Aparna C.
    McFatrich, Molly
    Mkumba, Laura
    Wright, Lauren
    Redlich, Carrie A.
    Snyder, Laurie D.
    Reeve, Bryce B.
    Patel, Divya
    Gulati, Mridu
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [4] Pregnancy Considerations for Patients With Interstitial Lung Disease
    Grant-Orser, Amanda
    Metcalfe, Amy
    Pope, Janet E.
    Johannson, Kerri A.
    CHEST, 2022, 162 (05) : 1093 - 1105
  • [5] A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease
    Dodia, Neal
    Amariei, Diana
    Kenaa, Blaine
    Corwin, Doug
    Chelala, Lydia
    Britt, E. James
    Sachdeva, Ashutosh
    Luzina, Irina G.
    Hasday, Jeffrey D.
    Shah, Nirav G.
    Atamas, Sergei P.
    Franks, Teri J.
    Burke, Allen P.
    Hines, Stella E.
    Galvin, Jeffrey R.
    Todd, Nevins W.
    RESPIRATORY MEDICINE, 2021, 179
  • [6] Contemporary Concise Review 2018: Interstitial lung disease
    Mari, Pier-Valerio
    Jones, Mark G.
    Richeldi, Luca
    RESPIROLOGY, 2019, 24 (08) : 809 - 816
  • [7] Interstitial lung disease related to smoking: imaging considerations
    Walsh, Simon L. F.
    Nair, Arjun
    Desai, Sujal R.
    CURRENT OPINION IN PULMONARY MEDICINE, 2015, 21 (04) : 407 - 416
  • [8] Heme Oxygenase-1 in Patients With Interstitial Lung Disease: A Review of the Clinical Evidence
    Hara, Yu
    Nakashima, Kentaro
    Nagasawa, Ryo
    Murohashi, Kota
    Tagami, Yoichi
    Aoki, Ayako
    Okudela, Koji
    Kaneko, Takeshi
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 362 (02) : 122 - 129
  • [9] Lung cancer and interstitial lung disease: a literature review
    Naccache, Jean-Marc
    Gibiot, Quentin
    Monnet, Isabelle
    Antoine, Martine
    Wislez, Marie
    Chouaid, Christos
    Cadranel, Jacques
    JOURNAL OF THORACIC DISEASE, 2018, 10 (06) : 3829 - +
  • [10] Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
    Wong, Alyson W.
    Fidler, Lee
    Marcoux, Veronica
    Johannson, Kerri A.
    Assayag, Deborah
    Fisher, Jolene H.
    Hambly, Nathan
    Kolb, Martin
    Morisset, Julie
    Shapera, Shane
    Ryerson, Christopher J.
    CHEST, 2020, 158 (03) : 1069 - 1078